Larentis Ariane Leites, Argondizzo Ana Paula Corrêa, Esteves Gabriela dos Santos, Jessouron Ellen, Galler Ricardo, Medeiros Marco Alberto
Fundação Oswaldo Cruz (Fiocruz), Bio-Manguinhos/VDTEC (Vice-Diretoria de Desenvolvimento Tecnológico), Laboratório de Tecnologia Recombinante (LATER), Av. Brasil 4365, 21.040-360, Rio de Janeiro - RJ, Brazil.
Protein Expr Purif. 2011 Jul;78(1):38-47. doi: 10.1016/j.pep.2011.02.013. Epub 2011 Mar 6.
The gene corresponding to mature PsaA from Streptococcus pneumoniae serotype 14 was cloned into a plasmid with kanamycin resistance and without a purification tag in Escherichia coli to express high levels of the recombinant protein for large-scale production as a potential vaccine candidate or as a carrier for polysaccharide conjugation at Bio-Manguinhos/Fiocruz. The evaluation of induction conditions (IPTG concentration, temperature and time) in E. coli was accomplished by experimental design techniques to enhance the expression level of mature recombinant PsaA (rPsaA). The optimization of induction process conditions led us to perform the recombinant protein induction at 25°C for 16 h, with 0.1mM IPTG in Terrific Broth medium. At these conditions, the level of mature rPsaA expression obtained in E. coli BL21 (DE3) Star by pET28a induction with IPTG was in the range of 0.8 g/L of culture medium, with a 10-fold lower concentration of inducer than usually employed, which contributes to a less expensive process. Mature rPsaA expressed in E. coli BL21 (DE3) Star accounted for approximately 30-35% of the total protein. rPsaA purification by ion exchange allowed the production of high-purity recombinant protein without fusion tags. The results presented in this work confirm that the purified recombinant protein maintains its stability and integrity for long periods of time in various storage conditions (temperatures of 4 or -70°C using different cryoprotectors) and for at least 3 years at 4 or -70°C in PBS. The conformation of the stored protein was confirmed using circular dichroism. Mature rPsaA antigenicity was proven by anti-rPsaA mouse serum recognition through western blot analysis, and no protein degradation was detected after long periods of storage.
将来自肺炎链球菌14型的成熟PsaA对应的基因克隆到带有卡那霉素抗性且无纯化标签的质粒中,在大肠杆菌中表达高水平的重组蛋白,以便在Bio-Manguinhos/Fiocruz进行大规模生产,作为潜在的疫苗候选物或作为多糖偶联的载体。通过实验设计技术评估大肠杆菌中的诱导条件(IPTG浓度、温度和时间),以提高成熟重组PsaA(rPsaA)的表达水平。诱导工艺条件的优化使我们在25°C下用0.1mM IPTG在Terrific Broth培养基中进行重组蛋白诱导16小时。在这些条件下,用IPTG诱导pET28a在大肠杆菌BL21(DE3) Star中获得的成熟rPsaA表达水平在每升培养基0.8克的范围内,诱导剂浓度比通常使用的低10倍,这有助于降低生产成本。在大肠杆菌BL21(DE3) Star中表达的成熟rPsaA约占总蛋白的30 - 35%。通过离子交换纯化rPsaA可生产无融合标签的高纯度重组蛋白。这项工作中呈现的结果证实,纯化的重组蛋白在各种储存条件下(使用不同冷冻保护剂在4或 -70°C)能长时间保持其稳定性和完整性,并且在4或 -70°C的PBS中至少可保存3年。使用圆二色性确认了储存蛋白的构象。通过蛋白质印迹分析,抗rPsaA小鼠血清识别证明了成熟rPsaA的抗原性,并且在长时间储存后未检测到蛋白质降解。